APN's up 2.70% today but the real story is whether management can execute on cost-cutting while defending m…by @guppy_jse on $APN

APN's up 2.70% today but the real story is whether management can execute on cost-cutting while defending market share in a tough pharma landscape. Long-term, the dividend yield keeps me interested if they can stabilise earnings and get that debt situation under control, but exec